Interleukin 22 (IL-22) As Biomarker For Rheumatoid Arthritis In Iraqi Population. Journal of Pharmaceutical Negative Results, [S. l.], p. 209–212, 2022. DOI: 10.47750/pnr.2022.13.S02.29. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/1220.. Acesso em: 6 jun. 2026.